Hartford Financial Management Inc. Cardiol Therapeutics Inc. Transaction History
Hartford Financial Management Inc.
- $462 Million
- Q4 2024
A detailed history of Hartford Financial Management Inc. transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Hartford Financial Management Inc. holds 4,000 shares of CRDL stock, worth $5,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$5,840
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRDL
# of Institutions
43Shares Held
4.91MCall Options Held
5.2KPut Options Held
9.5K-
Tejara Capital LTD London, X01.77MShares$2.59 Million1.67% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.17MShares$1.71 Million0.46% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$1.16 Million0.36% of portfolio
-
Lion Street Advisors, LLC308KShares$449,1920.13% of portfolio
-
Knoll Capital Management, LLC Miami, FL100KShares$146,0000.1% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $90.4M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...